Evidence map›Paper›PMID 25904601›Full record

Trial reportThe American journal of clinical nutrition2015

A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults.

Kimber L Stanhope, Valentina Medici, Andrew A Bremer, Vivien Lee, Hazel D Lam, Marinelle V Nunez, Guoxia X Chen, Nancy L Keim, Peter J Havel

4 registry-linked trialsOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 129 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 11 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01103921 nacompletednot on this map

Effects of 2-weeks Fructose & HFCS Consumption on Dyslipidemia & Insulin Resistance

TypeinterventionalSponsorUniversity of California, DavisRan2008 to 2014Enrolled214ConditionsMetabolic Syndrome, Insulin Resistance, DyslipidemiaArmsGlucose, Fructose, High-Fructose Corn Syrup, No sugar (Aspartame)
NCT02877823 nacompletednot on this mapstarted 2016, after this paper: background citation

A Community-based, Family Navigator Intervention to Improve Cardiometabolic Health of Medicaid-insured Youth Identified Through an Antipsychotic Medication Preauthorization Program

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2016 to 2021Enrolled302ConditionsChildhood ObesityArmsTreatment, Control
NCT03527277 nacompletednot on this mapstarted 2018, after this paper: background citation

The Effects of Orange Juice Compared With Sugar-sweetened Beverage on Risk Factors and Metabolic Processes Associated With the Development of Cardiovascular Disease and Type 2 Diabetes

TypeinterventionalSponsorUniversity of California, DavisRan2018 to 2023Enrolled56ConditionsCardiovascular Risk Factor, Type2 Diabetes Mellitus, Insulin Sensitivity, Metabolic SyndromeArmsNaturally-sweetened orange juice, Sugar-sweetened beverage
NCT03783195 nacompletednot on this mapstarted 2019, after this paper: background citation

Genetic-specific Effects of Fructose on Liver Lipogenesis

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2023Enrolled15ConditionsNAFLDArmsSugar drink
3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 11 syntheses or guidelines pooled it, 266 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kimber L StanhopeFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK). klstanhope@ucdavis.edu.
Valentina MediciFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Andrew A BremerFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Vivien LeeFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Hazel D LamFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Marinelle V NunezFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Guoxia X ChenFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Nancy L KeimFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Peter J HavelFrom the Department of Molecular Biosciences, School of Veterinary Medicine (KLS, VL, HDL, GXC, and PJH), the Department of Nutrition (KLS, MVN, NLK, and PJH), the Division of Gastroenterology and Hepatology, School of Medicine (VM), and the Department of Pediatrics, School of Medicine, University of California, Davis, Davis, CA (AAB); and US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA (NLK).
Western Human Nutrition Research Center · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
Building Interdisciplinary Research Careers in Womens Health at UC Davis - Administrative SupplementK12HD051958 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI LANE, NANCY E · 2005 to 2023
$9.6M
Adverse Metabolic Effects of Dietary Sugar _ Ad Libitum vs Energy-Balanced DietsR01HL121324 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAVEL, PETER J, SCHWARZ, JEAN-MARC · 2014 to 2019
$4.2M
Effects of 2wk fructose & HFCS consumption on lipid dysregulation & insulin resisR01HL091333 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAVEL, PETER J · 2008 to 2012
$2.0M
Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemiaR01HL107256 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAVEL, PETER J, SCHWARZ, JEAN-MARC · 2011 to 2014
$1.5M
NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR024146NHLBI NIH HHS 1R01 HL09133NHLBI NIH HHS 1R01 HL107256NHLBI NIH HHS R01 HL091333NHLBI NIH HHS R01 HL107256NHLBI NIH HHS R01 HL121324NICHD NIH HHS K12 HD051958
6 · The paper itself

Abstract

backgroundNational Health and Nutrition Examination Survey data show an increased risk of cardiovascular disease (CVD) mortality with an increased intake of added sugar.

objectiveWe determined the dose-response effects of consuming beverages sweetened with high-fructose corn syrup (HFCS) at zero, low, medium, and high proportions of energy requirements (Ereq) on circulating lipid/lipoprotein risk factors for CVD and uric acid in adults [age: 18-40 y; body mass index (in kg/m(2)): 18-35].

designWe conducted a parallel-arm, nonrandomized, double-blinded intervention study in which adults participated in 3.5 inpatient days of baseline testing at the University of California Davis Clinical and Translational Science Center's Clinical Research Center. Participants then consumed beverages sweetened with HFCS at 0% (aspartame sweetened, n = 23), 10% (n = 18), 17.5% (n = 16), or 25% (n = 28) of Ereq during 13 outpatient days and during 3.5 inpatient days of intervention testing at the research center. We conducted 24-h serial blood collections during the baseline and intervention testing periods.

resultsConsuming beverages containing 10%, 17.5%, or 25% Ereq from HFCS produced significant linear dose-response increases of lipid/lipoprotein risk factors for CVD and uric acid: postprandial triglyceride (0%: 0 ± 4; 10%: 22 ± 8; 17.5%: 25 ± 5: 25%: 37 ± 5 mg/dL, mean of Δ ± SE, P < 0.0001 effect of HFCS-dose), fasting LDL cholesterol (0%: -1.0 ± 3.1; 10%: 7.4 ± 3.2; 17.5%: 8.2 ± 3.1; 25%: 15.9 ± 3.1 mg/dL, P < 0.0001), and 24-h mean uric acid concentrations (0%: -0.13 ± 0.07; 10%: 0.15 ± 0.06; 17.5%: 0.30 ± 0.07; 25%: 0.59 ± 0.09 mg/dL, P < 0.0001). Compared with beverages containing 0% HFCS, all 3 doses of HFCS-containing beverages increased concentrations of postprandial triglyceride, and the 2 higher doses increased fasting and/or postprandial concentrations of non-HDL cholesterol, LDL cholesterol, apolipoprotein B, apolipoprotein CIII, and uric acid.

conclusionsConsuming beverages containing 10%, 17.5%, or 25% Ereq from HFCS produced dose-dependent increases in circulating lipid/lipoprotein risk factors for CVD and uric acid within 2 wk. These results provide mechanistic support for the epidemiologic evidence that the risk of cardiovascular mortality is positively associated with consumption of increasing amounts of added sugars. This trial was registered at clinicaltrials.gov as NCT01103921.

Indexed as

BeveragesAdolescentAdultApolipoprotein C-IIIApolipoproteins BBlood GlucoseBody Mass IndexCardiovascular DiseasesCholesterol, HDLCholesterol, LDLDose-Response Relationship, DrugDouble-Blind MethodFastingFemaleHigh Fructose Corn SyrupHumansApolipoprotein C-IIIApolipoproteins BBlood GlucoseCholesterol, HDLCholesterol, LDLHigh Fructose Corn SyrupSweetening AgentsTriglyceridesUric Acidapolipoprotein CIIIfructoserisk factorssugaruric acid

Identifiers

PMID25904601
PMCPMC4441807
OpenAlexW2043105362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.